CHEMOMAB THERAPEUTICS LTD (CMMB)

US16385C1045 - ADR

0.67  0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
N/A0.000.000.000.00
Cost Of Goods
N/A2.87MN/AN/AN/A
Gross Profit
N/A-2.87MN/AN/AN/A
Operating Expenses
25.46M25.66M12.37M10.96M19.55M
Research and Development
18.38M13.87M6.33M3.78M13.30M
Selling, General, and Administrative Expenses
7.08M11.80M6.03M7.18M6.25M
Operating Income
-25.46M-28.53M-12.37M-10.96M-19.55M
Interest Income/Expense
1.24M350.00K-110.00K100.00K340.00K
Other Income/Expense
N/AN/AN/AN/A-4.57M
Non Recurring Items
N/AN/AN/A-750.00K-3.35M
Income Before Taxes
-24.22M-28.18M-12.48M-11.61M-27.12M
Income Tax
0.00-530.00KN/AN/AN/A
Net Income
-24.22M-27.65M-12.48M-11.61M-27.12M
EBITDA
-25.39M-28.47M-12.34M-10.94M-19.27M
 
Per Share Data
EPS Diluted Total Ops
-1.89-35.55-17.59-91.80-230.87
Non GAAP EPS
N/A-1.75-1.18N/A-63.20
 
Statistics

All data in USD

Charts